4
Changes in Ownership
NEKTAR THERAPEUTICS Filed Acc 0001209191-19-053497
SVP, COO & CFO sold 25,000 shares at $15.83 ($395,750)
- SVP, COO & CFO acquired 25,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Labrucherie Gil M SVP, COO & CFO | 2019-10-15 | Option exercise | +25,000 | $7.21 | $180,250 | 252,872 | D |
| Labrucherie Gil M SVP, COO & CFO | 2019-10-15 | Sale | −25,000 | $15.83 | $395,750 | 227,872 | D |
| Derivatives | |||||||
| Labrucherie Gil M SVP, COO & CFO | 2019-10-15 | Option exercise · Stock Option | −25,000 | 25,000 | D | ||
| Open-market sales · 25,000 sh · avg $15.83 · $395,750 | |||||||
Loading xslF345X03/doc4.xml…